Insider · CIK 0001877701
Yehia Hashad
officerdirector
Files at UBX (Unity Biotechnology, Inc.), BLCO (Bausch & Lomb Corp). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +17,715 | $0.00 | $0 | 134,454 | Aug 7, 2025 |
| Jul 25, 2025 | BLCO Bausch & Lomb Corp | FTax withholding Common Shares, No Par Value | -2,841 | $14.32 | $41k | 116,739 | Jul 28, 2025 |
| Mar 8, 2025 | UBX Unity Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 10, 2025 |
| Feb 26, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +25,225 | $0.00 | $0 | 119,580 | Feb 28, 2025 |
| Feb 26, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Non-Qualified Stock Options (right to purchase)derivative | +60,085 | $0.00 | $0 | 60,085 | Feb 28, 2025 |
| Dec 23, 2024 | BLCO Bausch & Lomb Corp | FTax withholding Common Shares, No Par Value | -2,324 | $17.83 | $41k | 97,106 | Dec 26, 2024 |
| Dec 23, 2024 | BLCO Bausch & Lomb Corp | FTax withholding Common Shares, No Par Value | -2,751 | $17.83 | $49k | 94,355 | Dec 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.